22-02-2026 01:10 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 379.18
NSE Code AUROPHARMA
Dividend Yield % 0.00
Market Cap 673584.68
P/E 31.61
EPS 36.69
Face Value 1  
Description ( As On December 2025 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  13  283115075  48.75  283115075  
  Foreign Promoter  1  17833646  3.07  17833646  
  Total Promoter  14  300948721  51.82  300948721  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  39  113367285  19.52  113367285  
  FI/Bank/Insurance  22  31951074  5.5  31951074  
  Govt          
  FII          
  Other  633  96462070  16.61  96462070  
  Total Institutions  694  241780429  41.63  241780429  
 Non-Institution          
  Bodies Corporate  1267  2969671  0.51  2968561  
  Individuals          
  NRIs/OCBs  7035  2153680  0.37  2153680  
  Others  227849  32949122  5.68  32337120  
  Total Non-Institution  236151  38072473  6.56  37459361  
Total Non Promoter  236845  279852902  48.18  279239790  
          
  Depository Receipts          
          
Grand Total  236859  580801623  100  580188511  
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.